Helmerich & Payne Analyst Price Targets

Wall Street analyst price targets and consensus rating for Helmerich & Payne (HP).

Price Target Range — 13 Quarters

Analyst Consensus — 13 Analysts

5Buy

7Hold

1Sell

Consensus RatingOverweight# Analysts13Avg. Consensus PT$41Upside to Avg. PT+2.2%

Rating Trend — Last 9 Months

Recent Analyst Actions

모든 평가 보기 →

Date	Firm	Analyst	Action	Rating Change	Price Target
Oct 12, 2026	UBS	Josh Silverstein	PT Raise	Buy	$49→$50
Oct 12, 2026	Barclays	Eddie Kim	PT Raise	Overweight	$50→$51
Oct 5, 2026	Susquehanna	Charles Minervino	PT Raise	Positive	$44→$50
Oct 2, 2026	UBS	Josh Silverstein	Reinstates	Buy	$49
Sep 10, 2026	RBC Capital	Keith Mackey	PT Raise	Sector Perform	$44→$49
Sep 4, 2026	Citigroup	Scott Gruber	PT Raise	Neutral	$36→$48
Aug 20, 2026	Morgan Stanley	Joe Laetsch	PT Raise	Underweight	$36→$41
Aug 10, 2026	Barclays	Eddie Kim	PT Raise	Overweight	$47→$50
Aug 7, 2026	Susquehanna	Charles Minervino	PT Raise	Positive	$40→$44
Jul 8, 2026	Susquehanna	Charles Minervino	PT Cut	Positive	$43→$40
Jun 29, 2026	Citigroup	Scott Gruber	PT Cut	Neutral	$38→$36
Jun 4, 2026	Goldman Sachs	Neil Mehta	PT Raise	Neutral	$35→$41
May 18, 2026	Piper Sandler	Derek Podhaizer	PT Raise	Overweight	$41→$43
May 14, 2026	Morgan Stanley	Daniel Kutz	PT Raise	Underweight	$35→$39
May 8, 2026	RBC Capital	Keith Mackey	PT Raise	Sector Perform	$38→$40
May 8, 2026	Barclays	Eddie Kim	PT Raise	Overweight	$39→$47
May 8, 2026	Susquehanna	Charles Minervino	PT Raise	Positive	$42→$43
Apr 15, 2026	Morgan Stanley	Daniel Kutz	PT Raise	Underweight	$30→$35
Apr 15, 2026	Piper Sandler	Derek Podhaizer	PT Raise	Overweight	$40→$41
Apr 7, 2026	Susquehanna	Charles Minervino	PT Raise	Positive	$40→$42

Analyst Ratings News

PRO
UBS Maintains Buy on Helmerich & Payne, Raises Price Target to $50

UBS analyst Josh Silverstein maintains Helmerich & Payne (NYSE:HP) with a Buy and raises the price target from $49 to $50.

Benzinga Newsdesk

PRO
Barclays Maintains Overweight on Helmerich & Payne, Raises Price Target to $51

Barclays analyst Eddie Kim maintains Helmerich & Payne (NYSE:HP) with a Overweight and raises the price target from $50 to $51.

Benzinga Newsdesk

PRO
Susquehanna Maintains Positive on Helmerich & Payne, Raises Price Target to $50

Susquehanna analyst Charles Minervino maintains Helmerich & Payne (NYSE:HP) with a Positive and raises the price target from $44 to $50.

Benzinga Newsdesk

PRO
RBC Capital Maintains Sector Perform on Helmerich & Payne, Raises Price Target to $49

RBC Capital analyst Keith Mackey maintains Helmerich & Payne (NYSE:HP) with a Sector Perform and raises the price target from $44 to $49.

Benzinga Newsdesk

PRO
Citigroup Maintains Neutral on Helmerich & Payne, Raises Price Target to $48

Citigroup analyst Scott Gruber maintains Helmerich & Payne (NYSE:HP) with a Neutral and raises the price target from $36 to $48.

Benzinga Newsdesk

PRO
Morgan Stanley Maintains Underweight on Helmerich & Payne, Raises Price Target to $41

Morgan Stanley analyst Joe Laetsch maintains Helmerich & Payne (NYSE:HP) with a Underweight and raises the price target from $36 to $41.

Benzinga Newsdesk

Helmerich & Payne Inc

뉴스

파트너 / 기고자

벤징가 글로벌

Helmerich & Payne Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
UBS Maintains Buy on Helmerich & Payne, Raises Price Target to $50

PRO
Barclays Maintains Overweight on Helmerich & Payne, Raises Price Target to $51

PRO
Susquehanna Maintains Positive on Helmerich & Payne, Raises Price Target to $50

PRO
RBC Capital Maintains Sector Perform on Helmerich & Payne, Raises Price Target to $49

PRO
Citigroup Maintains Neutral on Helmerich & Payne, Raises Price Target to $48

PRO
Morgan Stanley Maintains Underweight on Helmerich & Payne, Raises Price Target to $41

People Also Watch

People Also Watch

Helmerich & Payne Inc

뉴스

파트너 / 기고자

벤징가 글로벌

Helmerich & Payne Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROUBS Maintains Buy on Helmerich & Payne, Raises Price Target to $50

PROBarclays Maintains Overweight on Helmerich & Payne, Raises Price Target to $51

PROSusquehanna Maintains Positive on Helmerich & Payne, Raises Price Target to $50

PRORBC Capital Maintains Sector Perform on Helmerich & Payne, Raises Price Target to $49

PROCitigroup Maintains Neutral on Helmerich & Payne, Raises Price Target to $48

PROMorgan Stanley Maintains Underweight on Helmerich & Payne, Raises Price Target to $41

People Also Watch

People Also Watch

PRO
UBS Maintains Buy on Helmerich & Payne, Raises Price Target to $50

PRO
Barclays Maintains Overweight on Helmerich & Payne, Raises Price Target to $51

PRO
Susquehanna Maintains Positive on Helmerich & Payne, Raises Price Target to $50

PRO
RBC Capital Maintains Sector Perform on Helmerich & Payne, Raises Price Target to $49

PRO
Citigroup Maintains Neutral on Helmerich & Payne, Raises Price Target to $48

PRO
Morgan Stanley Maintains Underweight on Helmerich & Payne, Raises Price Target to $41